| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/04/2003 | US6528704 Of given nucleotide sequence, capable of driving transcription; can use to confer important traits for agronomics, insect resistance, disease resistance, herbicide resistance, and grain characteristics |
| 03/04/2003 | US6528702 Plant genes and uses thereof |
| 03/04/2003 | US6528701 Rice ubiquitin-derived promoters |
| 03/04/2003 | US6528699 Inserting nucleic acid construct which comprises promoter, milk protein specific signal sequence; can use for treating diabetes and multiple sclerosis |
| 03/04/2003 | US6528639 Active ribozyme |
| 03/04/2003 | US6528637 Fatty acid synthase mRNA binding protein |
| 03/04/2003 | US6528635 Tumor antigen protein, gene thereof, and utilization thereof |
| 03/04/2003 | US6528634 Aiolos gene |
| 03/04/2003 | US6528633 Cyclin-selective ubiquitin carrier polypeptides |
| 03/04/2003 | US6528631 Folates are conjugated to an oligonucleotide including at the 2'-, 3'-, 5'-, nucleobase and internucleotide linkage sites; improved transfer across cellular membranes; regioselective synthesis |
| 03/04/2003 | US6528630 Calcium channel compositions and methods |
| 03/04/2003 | US6528626 Viral library for use in the diagnosis and treatment of viral diseases |
| 03/04/2003 | US6528623 Antibodies that specifically bind ACT-4-L-h-1 ligand |
| 03/04/2003 | US6528621 Mammalian cytokine-like factor-7 |
| 03/04/2003 | US6528620 MSin3A Interaction Domain (SID); 13 amino acid polypeptide sequence; Mad proteins; DNA transcription repressor; chimeric transcriptional repressors |
| 03/04/2003 | US6528619 Cyclic peptide binding inhibitors; structural formulas; use drugs for diseases mediated by urokinase and receptor; tumors; inflammation; angiogenesis |
| 03/04/2003 | US6528618 Synthetic peptides; serine proteases; human leukocyte elastase; cathepsin G; chronic inflamation conditons; rheumatoid arthritis; pulmonary emphysema; cystic fibrosis; bronchitis; asthma |
| 03/04/2003 | US6528493 Modulating activity of endogenous protein |
| 03/04/2003 | US6528488 Method for treating cystic fibrosis |
| 03/04/2003 | US6528487 Including GMP-140, ELAM-1, and lymphocyte-homing receptor. |
| 03/04/2003 | US6528486 Peptide agonists of GLP-1 activity |
| 03/04/2003 | US6528484 Photorhabdus luminescens (formerly Xenorhabdus luminescens) |
| 03/04/2003 | US6528482 Receptor activator of NF-κB |
| 03/04/2003 | US6528480 MF2 protein having antiviral and/or antifungal activities from Bacillus thuringiensis |
| 03/04/2003 | US6528479 Dominant negative mutants of IRS-1 and uses thereof |
| 03/04/2003 | US6528314 Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made |
| 03/04/2003 | US6528313 Production of transgenic animals; targeted replacement of an endogenous gene; genetic trait expression |
| 03/04/2003 | US6528312 Nuclease inhibitor (G-Actin) or interleukin-10 (IL-10) use improving cell transfection; mixtures; polynucleotides; use gene therapy, vaccines |
| 03/04/2003 | US6528311 Molecular genetic techniques to generate new or improved biological properties of organisms or cells; genetic recombination; locked in prophage; protein/metabolite expression; meiosis |
| 03/04/2003 | US6528310 Cancer control |
| 03/04/2003 | US6528308 Type-1 Human Immunodeficiency Virus (HIV-1); Permanently established lymphocyte cell lines that produce an antiviral compound; CD8+ suppressor molecule |
| 03/04/2003 | US6528304 Eukaryotic cells expressing at their surface at least an HLA-G isoform and their applications |
| 03/04/2003 | US6528303 Neuropeptide Y-Y5 receptor |
| 03/04/2003 | US6528300 Glutaryl cephalosporin amidase from Pseudomonas diminuta BS-203 |
| 03/04/2003 | US6528299 Inhibited by aprotinin; increased activity by calcium ions and/or heparin or related substances; proenzyme; use in therapy or prophylaxis of bleeding events, wound healing, disorders caused by fibrin-containing thrombin |
| 03/04/2003 | US6528289 Nucleotide sequence of the Haemophilus influenzae Rd genome, fragments thereof, and uses thereof |
| 03/04/2003 | US6528287 Recombinant human serum transferrins containing peptides for inducing apoptosis in HIV-1 infected cells |
| 03/04/2003 | US6528284 S-Region Transfer Activity-70 (SRTA-70); can be used as therapeutic agents in immune response modulation |
| 03/04/2003 | US6528283 Members of the D52 Gene family |
| 03/04/2003 | US6528281 DNA encoding human interleukin-11 receptor |
| 03/04/2003 | US6528276 Fusion proteins, DNA molecules, vectors, and host cells useful for measuring protease activity |
| 03/04/2003 | US6528271 Drug screening |
| 03/04/2003 | US6528270 Methods for identifying compounds for treatment of cell proliferative disorders associated with adaptor protein interactions |
| 03/04/2003 | US6528269 Monoclonal antibodies; can be used to diagnose neurodegenerative disorders |
| 03/04/2003 | US6528265 DNA sequences specific to WA (wild abortive) cytoplasmic male sterile lines of rice, use in a Polymerase Chain Reaction (PCR) assay to distinguish Male Sterile lines of rice from their cognate Male Fertile Maintainer Lines |
| 03/04/2003 | US6528263 Identifying a cell expressing protooncogene polypeptide by contacting a nucleic acid with a polynucleotide reagent and detecting its binding; can be used in diagnosis and treatment of cancer |
| 03/04/2003 | US6528261 Method for typing of HLA alleles |
| 03/04/2003 | US6528253 Compositions and methods for diagnosis of ovarian cancer |
| 03/04/2003 | US6528250 Administering multiple low doses of the virus using intravenous route |
| 03/04/2003 | US6528246 Method for the inactivation of non-lipid-coated viruses |
| 03/04/2003 | US6528066 Variant varicella-zoster viruses and methods of use |
| 03/04/2003 | US6528064 Recombinant trytophan mutants of influenza |
| 03/04/2003 | US6528061 purified immunogenic polypeptide comprising a polysaccharide mimotope recognized by a protective monoclonal antibody having a specificity for a surface polysaccharide of a bacterium of the Shigella species, said surface polysaccharide |
| 03/04/2003 | US6528060 Therapeutic compounds |
| 03/04/2003 | US6528055 Polypeptide for use in the diagnosis, treatment and prevention of infections, immune response defects and autoimmune diseases |
| 03/04/2003 | US6528054 Comprise one or more breast tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions. Alternatively, a therapeutic composition may comprise an antigen presenting cell that expresses a breast |
| 03/04/2003 | US6528050 Polypeptide growth factors, methods of making them, polynucleotides encoding them, antibodies to them, and methods of using them are disclosed. The polypeptides comprise an amino acid segment that is at least 90% identical to residues |
| 03/04/2003 | US6528038 An immune response directed against Porphyromonas gingivalis. The composition includes a suitable adjuvant and/or acceptable carrier and one substantially purified P. gingivalis immunogen. The immunogen is selected from the group consisting |
| 03/04/2003 | US6527689 Maternally transcribed protein |
| 03/04/2003 | CA1341423C Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome |
| 03/01/2003 | WO2003000027A2 Blocking peptide for inflammatory cell secretion |
| 03/01/2003 | CA2452123A1 Blocking peptide for inflammatory cell secretion |
| 02/28/2003 | CA2400887A1 Production of therapeutic proteins in transgenic cereal crops |
| 02/28/2003 | CA2400531A1 Human nhe2 |
| 02/28/2003 | CA2400521A1 Gpcr subfamily sequence motifs, and methods for gpcr characterization |
| 02/28/2003 | CA2396891A1 Generation of transgenic mouse models for the development of prostate cancer using regulatory regions of the psp94 gene |
| 02/28/2003 | CA2357181A1 Generation of transgenic mouse models for the development of prostate cancer using regulatory regions of the psp94 gene |
| 02/28/2003 | CA2356473A1 Production of a herpes vaccine in the seeds of a cereal crop |
| 02/27/2003 | WO2003017032A2 Computer-based methods of designing molecules |
| 02/27/2003 | WO2003016917A2 Sodium channel regulators and modulators |
| 02/27/2003 | WO2003016913A1 Suppression of cross-reactivity and non-specific binding by antibodies using protein a |
| 02/27/2003 | WO2003016571A1 Zinc finger domain libraries |
| 02/27/2003 | WO2003016562A2 Compositions and methods for detecting multidrug resistant strains of m. tuberculosis having mutations in genes of the mutt family |
| 02/27/2003 | WO2003016553A2 Gpcr-like retinoic acid-induced gene 1 protein and nucleic acid |
| 02/27/2003 | WO2003016549A2 Nucleic-acid associated proteins |
| 02/27/2003 | WO2003016542A1 Obesity related genes expressed at least in the hypothalamus |
| 02/27/2003 | WO2003016538A1 A method or extracellular production of target proteins employing ompf in e. coli |
| 02/27/2003 | WO2003016536A2 Plasmids from anaerocellum thermophilum and uses thereof |
| 02/27/2003 | WO2003016533A1 GENE qSH-1 INDUCING PLANT THRESHABILITY AND UTILIZATION OF THE SAME |
| 02/27/2003 | WO2003016532A1 Human protooncogene kg-20 and protein encoded therein |
| 02/27/2003 | WO2003016531A1 RNA-BINDING PROTEIN Musashi 2 |
| 02/27/2003 | WO2003016530A1 Novel protein and its dna |
| 02/27/2003 | WO2003016529A1 Novel blomia tropicalis antigens and uses therefor |
| 02/27/2003 | WO2003016523A1 Screen for cdc7 inhibitors |
| 02/27/2003 | WO2003016522A2 Methods and compounds for the targeting of protein to exosomes |
| 02/27/2003 | WO2003016520A1 Anti-aging and wound healing compounds |
| 02/27/2003 | WO2003016512A1 Method for improving methods of immunotherapy |
| 02/27/2003 | WO2003016511A1 Method of extended culture for antigen-specific cytotoxic t lumphocytes |
| 02/27/2003 | WO2003016510A1 New biopesticide using gene from erwinia pyrifoliaewt#3, novel pathogen that affects asian pear trees |
| 02/27/2003 | WO2003016506A2 Secreted proteins |
| 02/27/2003 | WO2003016505A2 Kgf polypeptide compositions |
| 02/27/2003 | WO2003016502A2 Tramdorins and methods of using tramdorins |
| 02/27/2003 | WO2003016499A2 Combinatorial methods for inducing cancer cell death |
| 02/27/2003 | WO2003016497A2 Molecules for disease detection and treatment |
| 02/27/2003 | WO2003016496A2 Zinc finger binding domains for cnn |
| 02/27/2003 | WO2003016495A2 Transgenic rodents as animal models for modulation of b1 bradykinin receptor protein |
| 02/27/2003 | WO2003016493A2 Transporters and ion channels |
| 02/27/2003 | WO2003016491A2 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma |
| 02/27/2003 | WO2003016489A2 Porcine leptin protein, antisense and antibody |
| 02/27/2003 | WO2003016487A2 Mammalian relaxin receptors |